{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T23:13:47Z","timestamp":1772234027396,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["K08-AI106420"],"award-info":[{"award-number":["K08-AI106420"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR002243"],"award-info":[{"award-number":["UL1 TR002243"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Treatment of tuberculosis infection (TBI) in individuals at high risk for tuberculosis (TB) disease is a priority for TB elimination in the US. Newly arrived refugees in Middle Tennessee are screened for TBI, but factors associated with gaps in the TBI care cascade are not well characterized.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We assessed the TBI care cascade from US entry to completion of treatment for refugees who resettled in Middle Tennessee from 2012 through 2016. We assessed factors associated with treatment initiation and completion using logistic regression models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 6776 refugees who completed initial health screening, 1681 (25%) screened positive for TBI, 1208 were eligible for treatment, 690 started treatment, and 432 completed treatment. Male sex (Odds Ratio [OR]: 1.42; 95% Confidence Interval [CI]: 1.06, 1.89) and screening with interferon gamma release assay compared to tuberculin skin test (OR: 2.89; 95% CI: 1.59, 5.27) were associated with increased treatment initiation; living farther away from TB clinic was associated with decreased treatment initiation (OR: 0.91; 95% CI: 0.83, 0.99). Existing diabetes (OR: 7.27; 95% CI: 1.93, 27.30), receipt of influenza vaccination (OR: 1.65; 95% CI: 1.14, 2.40) and region of origin from South-Eastern or Southern Asia (OR<jats:sub>SEAsia<\/jats:sub>: 2.30; 95% CI: 1.43, 3.70; OR<jats:sub>SAsia<\/jats:sub>: 1.64; 95% CI: 1.02, 2.64) were associated with increased treatment completion. Six refugees developed TB disease after declining (<jats:italic>n<\/jats:italic>\u2009=\u20094) or partially completing (<jats:italic>n<\/jats:italic>\u2009=\u20092) TBI treatment; none who completed treatment developed TB disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We determined gaps in the TBI care cascade among refugees in Middle Tennessee. Further assessment of barriers to treatment initiation and completion and interventions to assist refugees are warranted to improve these gaps and prevent TB disease.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12879-020-05311-0","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T18:03:56Z","timestamp":1597082636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Gaps in the care cascade for screening and treatment of refugees with tuberculosis infection in Middle Tennessee: a retrospective cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Adoma","family":"Manful","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Waller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Cummins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Warkentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Billy","family":"Reagon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Shaw-Kaikai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7631-9796","authenticated-orcid":false,"given":"Yuri F.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,10]]},"reference":[{"key":"5311_CR1","doi-asserted-by":"crossref","unstructured":"Talwar A. Tuberculosis \u2014 United States, 2018. MMWR Morb Mortal Wkly Rep [Internet]. 2019;68 Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/68\/wr\/mm6811a2.htm, [cited 2019 Sep 10]..","DOI":"10.15585\/mmwr.mm6811a2"},{"issue":"5","key":"5311_CR2","first-page":"480","volume":"12","author":"A Fok","year":"2008","unstructured":"Fok A, Numata Y, Schulzer M, FitzGerald MJ. Risk factors for clustering of tuberculosis cases: a systematic review of population-based molecular epidemiology studies [review article]. Int J Tuberc Lung Dis. 2008;12(5):480\u201392..","journal-title":"Int J Tuberc Lung Dis"},{"key":"5311_CR3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12916-016-0595-5","volume":"14","author":"M Pareek","year":"2016","unstructured":"Pareek M, Greenaway C, Noori T, Munoz J, Zenner D. The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med. 2016;14:48..","journal-title":"BMC Med"},{"key":"5311_CR4","unstructured":"CDC | TB | Latent Tuberculosis Infection | Guide...: Targeted Tuberculin Testing & Treatment of Latent TB Infection [Internet]. [cited 2017 Jun 15]. Available from: https:\/\/www.cdc.gov\/tb\/publications\/ltbi\/default.htm.."},{"key":"5311_CR5","unstructured":"Tuberculosis Guidelines and Recommendations [Internet]. [cited 2018 Mar 29]. Available from: https:\/\/www.tn.gov\/health\/cedep\/tuberculosis-elimination-program\/tuberculosis-guidelines-and-recommendations.html.."},{"key":"5311_CR6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12879-016-1550-y","volume":"16","author":"A Sandgren","year":"2016","unstructured":"Sandgren A, Vonk Noordegraaf-Schouten M, van Kessel F, Stuurman A, Oordt-Speets A, van der Werf MJ. Initiation and completion rates for latent tuberculosis infection treatment: a systematic review. BMC Infect Dis. 2016;16:204..","journal-title":"BMC Infect Dis"},{"key":"5311_CR7","volume-title":"USCIS","author":"The United States Refugee Admissions Program (USRAP) Consultation & Worldwide Processing Priorities [Internet]","year":"2019","unstructured":"The United States Refugee Admissions Program (USRAP) Consultation & Worldwide Processing Priorities [Internet]. USCIS. 2019. Available from: https:\/\/www.uscis.gov\/humanitarian\/refugees-asylum\/refugees\/united-states-refugee-admissions-program-usrap-consultation-worldwide-processing-priorities, [cited 2019 May 20].."},{"key":"5311_CR8","volume-title":"USCIS","author":"Refugee Processing and Security Screening [Internet]","year":"2018","unstructured":"Refugee Processing and Security Screening [Internet]. USCIS. 2018. Available from: https:\/\/www.uscis.gov\/refugeescreening, [cited 2019 May 20].."},{"key":"5311_CR9","unstructured":"Newly Arrived Immigrants & Refugees - Chapter 8\u20132018 Yellow Book | Travelers\u2019 Health | CDC [Internet]. [cited 2019 May 21]. Available from: https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2018\/advising-travelers-with-specific-needs\/newly-arrived-immigrants-refugees.."},{"key":"5311_CR10","unstructured":"Refugee Health Guidelines | Immigrant and Refugee Health | CDC [Internet]. 2019 [cited 2019 Jun 28]. Available from: https:\/\/www.cdc.gov\/immigrantrefugeehealth\/guidelines\/refugee-guidelines.html.."},{"key":"5311_CR11","volume-title":"Federal Register","author":"Medical Examination of Aliens-Revisions to Medical Screening Process [Internet]","year":"2016","unstructured":"Medical Examination of Aliens-Revisions to Medical Screening Process [Internet]. Federal Register. 2016. Available from: https:\/\/www.federalregister.gov\/documents\/2016\/01\/26\/2016-01418\/medical-examination-of-aliens-revisions-to-medical-screening-process, [cited 2018 Jan 3].."},{"issue":"3","key":"5311_CR12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5588\/ijtld.16.0469","volume":"21","author":"RN Moro","year":"2017","unstructured":"Moro RN, Sterling TR, Saukkonen J, Vernon A, Horsburgh CR, Chaisson RE, et al. Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial. Int J Tuberc Lung Dis. 2017;21(3):286\u201396..","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"5311_CR13","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/cid\/ciw126","volume":"62","author":"RN Moro","year":"2016","unstructured":"Moro RN, Borisov AS, Saukkonen J, Khan A, Sterling TR, Villarino ME, et al. Factors associated with noncompletion of latent tuberculosis infection treatment: experience from the PREVENT TB trial in the United States and Canada. Clin Infect Dis. 2016;62(11):1390\u2013400..","journal-title":"Clin Infect Dis"},{"issue":"2","key":"5311_CR14","first-page":"34","volume":"100","author":"T Rogo","year":"2017","unstructured":"Rogo T, Eleanya C, Hirway P, Pelland D, Lewis C, Dennehy P, et al. Adherence to Latent Tuberculosis Infection Treatment in a Population with a High Number of Refugee Children. R I Med J (2013). 2017;100(2):34\u20138..","journal-title":"R I Med J (2013)"},{"issue":"1","key":"5311_CR15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5588\/ijtld.14.0373","volume":"19","author":"Y Hirsch-Moverman","year":"2015","unstructured":"Hirsch-Moverman Y, Shrestha-Kuwahara R, Bethel J, Blumberg HM, Venkatappa TK, Horsburgh CR, et al. Latent tuberculous infection in the United States and Canada: who completes treatment and why? Int J Tuberc Lung Dis. 2015;19(1):31\u20138..","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"5311_CR16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.09-0394","volume":"137","author":"CR Horsburgh","year":"2010","unstructured":"Horsburgh CR, Goldberg S, Bethel J, Chen S, Colson PW, Hirsch-Moverman Y, et al. Latent TB infection treatment acceptance and completion in the United States and Canada. Chest. 2010;137(2):401\u20139..","journal-title":"Chest."},{"issue":"11","key":"5311_CR17","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","volume":"16","author":"H Alsdurf","year":"2016","unstructured":"Alsdurf H, Hill PC, Matteelli A, Getahun H, Menzies D. The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(11):1269\u201378..","journal-title":"Lancet Infect Dis"},{"key":"5311_CR18","doi-asserted-by":"crossref","unstructured":"Stuurman AL, Vonk Noordegraaf-Schouten M, van Kessel F, Oordt-Speets AM, Sandgren A, van der Werf MJ. Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review. BMC Infect Dis [Internet]. 2016;16 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4897858\/..","DOI":"10.1186\/s12879-016-1549-4"},{"key":"5311_CR19","unstructured":"CDC | TB | LTBI - Diagnosis of Latent TB Infection [Internet]. [cited 2017 Apr 28]. Available from: https:\/\/www.cdc.gov\/tb\/publications\/ltbi\/diagnosis.htm.."},{"key":"5311_CR20","volume-title":"CDC [Internet]","author":"Electronic Disease Notification System","year":"2019","unstructured":"Electronic Disease Notification System. Immigrant and Refugee Health. In: CDC [Internet]; 2019. Available from: https:\/\/www.cdc.gov\/immigrantrefugeehealth\/Electronic-Disease-Notification-System.html, [cited 2019 Apr 15].."},{"key":"5311_CR21","volume-title":"CDC [Internet]","author":"NBS Overview","year":"2019","unstructured":"NBS Overview | CDC [Internet]. 2019. Available from: https:\/\/www.cdc.gov\/nbs\/overview\/index.html, [cited 2019 Apr 15].."},{"issue":"1","key":"5311_CR22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8\u201327..","journal-title":"Med Care"},{"issue":"11","key":"5311_CR23","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J-C, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130\u20139..","journal-title":"Med Care"},{"issue":"7","key":"5311_CR24","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1371\/journal.pmed.0050152","volume":"5","author":"CY Jeon","year":"2008","unstructured":"Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7):e152..","journal-title":"PLoS Med"},{"issue":"1","key":"5311_CR25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00126334-200001010-00010","volume":"23","author":"R Wood","year":"2000","unstructured":"Wood R, Maartens G, Lombard CJ. Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr. 2000;23(1):75\u201380..","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5311_CR26","unstructured":"UNSD \u2014 Methodology [Internet]. [cited 2020 Mar 25]. Available from: https:\/\/unstats.un.org\/unsd\/methodology\/m49\/.."},{"key":"5311_CR27","unstructured":"BatchGeo: Create an interactive map from your data [Internet]. [cited 2018 Mar 30]. Available from: https:\/\/batchgeo.com\/.."},{"issue":"1","key":"5311_CR28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201308-1480OC","volume":"189","author":"ND Walter","year":"2014","unstructured":"Walter ND, Painter J, Parker M, Lowenthal P, Flood J, Fu Y, et al. Persistent latent tuberculosis reactivation risk in United States immigrants. Am J Respir Crit Care Med. 2014;189(1):88\u201395..","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"5311_CR29","first-page":"711","volume":"8","author":"JF Levesque","year":"2004","unstructured":"Levesque JF, Dongier P, Brassard P, Allard R. Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada. Int J Tuberc Lung Dis. 2004;8(6):711\u20137..","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"5311_CR30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0277-9536(93)90286-D","volume":"37","author":"EM Rathgeber","year":"1993","unstructured":"Rathgeber EM, Vlassoff C. Gender and tropical diseases: a new research focus. Soc Sci Med. 1993;37(4):513\u201320..","journal-title":"Soc Sci Med"},{"key":"5311_CR31","unstructured":"Physician attitudes regarding bacille Calmette-Gu\u00e9rin vaccination and treatment of latent tuberculosis infection. - PubMed - NCBI [Internet]. [cited 2019 May 21]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15636490.."},{"key":"5311_CR32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.copsyc.2015.03.012","volume":"5","author":"R Ferrer","year":"2015","unstructured":"Ferrer R, Klein WM. Risk perceptions and health behavior. Curr Opin Psychol. 2015;5:85\u20139..","journal-title":"Curr Opin Psychol"},{"key":"5311_CR33","volume-title":"The Oxford Handbook of Health Communication, Behavior Change, and Treatment Adherence [Internet]","author":"EA Waters","year":"2013","unstructured":"Waters EA, McQueen A, Cameron LD. Perceived Risk and its Relationship to Health-Related Decisions and Behavior. In: The Oxford Handbook of Health Communication, Behavior Change, and Treatment Adherence [Internet]; 2013. Available from: https:\/\/www.oxfordhandbooks.com\/view\/10.1093\/oxfordhb\/9780199795833.001.0001\/oxfordhb-9780199795833-e-013[cited 2019 May 21].."},{"issue":"6","key":"5311_CR34","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/rccm.200510-1667OC","volume":"174","author":"FK Shieh","year":"2006","unstructured":"Shieh FK, Snyder G, Horsburgh CR, Bernardo J, Murphy C, Saukkonen JJ. Predicting non-completion of treatment for latent tuberculous infection: a prospective survey. Am J Respir Crit Care Med. 2006;174(6):717\u201321..","journal-title":"Am J Respir Crit Care Med"},{"key":"#cr-split#-5311_CR35.1","doi-asserted-by":"crossref","unstructured":"Schmid P, Rauber D, Betsch C, Lidolt G, Denker M-L. Barriers of Influenza Vaccination Intention and Behavior - A Systematic Review of Influenza Vaccine Hesitancy, 2005-2016. PLoS One [Internet]. 2017;12","DOI":"10.1371\/journal.pone.0170550"},{"key":"#cr-split#-5311_CR35.2","unstructured":"(1) Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5268454\/, [cited 2019 May 21].."},{"key":"5311_CR36","unstructured":"Journey Of A Refugee [Internet]. [cited 2019 Jun 7]. Available from: http:\/\/www.empowernashville.org\/journey-of-a-refugee\/.."},{"key":"5311_CR37","unstructured":"About Refugee Social Services [Internet]. Office of Refugee Resettlement | ACF. [cited 2019 Jun 7]. Available from: https:\/\/www.acf.hhs.gov\/orr\/programs\/refugee-social-services\/about.."},{"key":"5311_CR38","unstructured":"Resettlement [Internet]. [cited 2019 Jun 7]. Available from: http:\/\/www.empowernashville.org\/resettlement\/.."},{"key":"5311_CR39","volume-title":"CDC [Internet]","author":"Screening for Viral Hepatitis During the Domestic Medical Examination of Newly Arrived Refugees","year":"2019","unstructured":"Screening for Viral Hepatitis During the Domestic Medical Examination of Newly Arrived Refugees. Immigrant and Refugee Health. In: CDC [Internet]; 2019. [cited 2019 May 21]. Available from: https:\/\/www.cdc.gov\/immigrantrefugeehealth\/guidelines\/domestic\/hepatitis-screening-guidelines.html.."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05311-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05311-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05311-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T11:51:50Z","timestamp":1667735510000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05311-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,10]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5311"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05311-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,10]]},"assertion":[{"value":"31 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Siloam Family Health Center and the Institutional Review Boards of Vanderbilt University and Metro Public Health Department reviewed and approved this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"592"}}